Clinical Trial Update: Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating iptacopan added to standard of care in adults with immunoglobulin A nephropathy to assess biopsy changes; recruitment is ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunoglobulin Nephropathy

Drugs mentioned

• iptacopan (iptacopan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Glomerulonephritis, IGA, Immunoglobulin A Nephropathy | Phase 2 | Status: RECRUITING